Patents by Inventor Ann Gee Lisa Ooi

Ann Gee Lisa Ooi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT AND/OR PREVENTION OF A VIRAL INFECTION
    Publication number: 20230355602
    Abstract: A method of treating or preventing a viral infection comprising administering a DHODH inhibitor to a patient in need thereof. Also provided is the use of the DHODH inhibitor for the treatment or prevention of a viral infection, alone or in combination with another therapy, and formulations or compositions comprising the DHODH inhibitor suitable for treating or preventing viral infections.
    Type: Application
    Filed: August 30, 2021
    Publication date: November 9, 2023
    Inventors: Bertil LINDMARK, Mark MCHALE, Ann Gee Lisa OOI, Qihui SEET, Eng Eong OOI
  • Cancer therapy
    Patent number: 11382903
    Abstract: A method of treating haematological cancer with a therapy comprising a DHODH inhibitor. Also provided is a combination therapy comprising a pan-HER inhibitor and a DHODH inhibitor for treating a haematological cancer.
    Type: Grant
    Filed: October 8, 2018
    Date of Patent: July 12, 2022
    Assignee: Aslan Pharmaceuticals Pte. Ltd.
    Inventors: Bertil Lindmark, Ann Gee Lisa Ooi, Mark Thomas McHale
  • Cancer therapy
    Patent number: 11311548
    Abstract: A method of treating haematological cancer with a therapy comprising a DHODH inhibitor. Also provided is a combination therapy comprising a pan-HER inhibitor and a DHODH inhibitor for treating a haematological cancer.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: April 26, 2022
    Assignee: Aslan Pharmaceuticals Pte. Ltd.
    Inventors: Bertil Lindmark, Ann Gee Lisa Ooi, Mark Thomas McHale
  • METHOD OF TREATMENT USING IL-13R ANTIBODY
    Publication number: 20200165347
    Abstract: The present disclosure provides a method of treating cutaneous T cell lymphoma (CTCL), in particular mycosis fungoides and/or Sézary syndrome, comprising administering a therapeutically effective amount of an antagonist antibody or binding fragment thereof specific to the IL-13 receptor to a patient in need thereof.
    Type: Application
    Filed: June 29, 2018
    Publication date: May 28, 2020
    Inventors: Bertil Lindmark, Ann Gee Lisa Ooi
  • CANCER THERAPY
    Publication number: 20190151326
    Abstract: A method of treating haematological cancer with a therapy comprising a DHODH inhibitor. Also provided is a combination therapy comprising a pan-HER inhibitor and a DHODH inhibitor for treating a haematological cancer.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 23, 2019
    Applicant: Aslan Pharmaceuticals Pte. Ltd.
    Inventors: Bertil Lindmark, Ann Gee Lisa Ooi
  • CANCER THERAPY
    Publication number: 20190038610
    Abstract: A method of treating haematological cancer with a therapy comprising a DHODH inhibitor. Also provided is a combination therapy comprising a pan-HER inhibitor and a DHODH inhibitor for treating a haematological cancer.
    Type: Application
    Filed: October 8, 2018
    Publication date: February 7, 2019
    Applicant: Aslan Pharmaceuticals Pte. Ltd.
    Inventors: Bertil Lindmark, Ann Gee Lisa Ooi